NEW YORK, Nov. 10, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AstraZeneca PLC ("AstraZeneca" or the "Company") (NASDAQ: AZN). Such investors are advised to ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Veterans Day holiday, CPI inflation, Powell comments, retail sales, earnings from Home Depot, Walt Disney and Cisco ...

Astrazeneca is set to report earnings next week after a turbulant few months for the FTSE 100 firm and its China arm.

What a wicked game insurers play with their customers. A reader contacted me last week about his experience with Hastings ...

For example, during the event, AstraZeneca shared promising early data for its oral GLP-1 candidate, AZD5004, and told Fierce ...

The OBR (Office for Budget Responsibility) anticipates economic output in Britain to expand by 1.8% in 2026 and by 1.5% in ...

In the coming truncated week, the markets are expected to consolidate further with stock-specific action due to global ...

IonQ has shown remarkable stock performance despite being labeled "risky" and "unproven". Find out why I'm bullish on IONQ ...

The Mayors officially opened The Glasshouse, Innovate Cambridge’s new innovation hub (Image: Supplied) The tour on November 5 ...